Pradeep K Dudeja

Prof. Pradeep K Dudeja

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
RGRavinder Gill
Ravinder Gill
SSSeema Saksena
Seema Saksena
WAWaddah A. Alrefai
Waddah A. Alrefai
ZSZaheer Sarwar
Zaheer Sarwar
JGJay L. Goldstein
Jay L. Goldstein
PDPradeep K Dudeja
Pradeep K Dudeja
Recent studies from our laboratory and others have demonstrated the involvement of monocarboxylate transporter (MCT)1 in the luminal uptake of short-chain fatty acids (SCFAs) in the human intestine. Functional studies from our laboratory previously demonstrated kinetically distinct SCFA transporters on the apical and basolateral membranes of human colonocytes. Although apical SCFA uptake is mediated by the MCT1 isoform, the molecular identity of the basolateral membrane SCFA transporter(s) and whether this transporter is encoded by another MCT isoform is not known. The present studies were designed to assess the expression and membrane localization of different MCT isoforms in human small intestine and colon. Immunoblotting was performed with the purified apical and basolateral membranes from human intestinal mucosa obtained from organ donor intestine. Immunohistochemistry studies were done on paraffin-embedded sections of human colonic biopsy samples. Immunoblotting studies detected a protein band of ∼39 kDa for MCT1, predominantly in the apical membranes. The relative abundance of MCT1 mRNA and protein increased along the length of the human intestine. MCT4 (54 kDa) and MCT5 (54 kDa) isoforms showed basolateral localization and were highly expressed in the distal colon. Immunohistochemical studies confirmed that human MCT1 antibody labeling was confined to the apical membranes, whereas MCT5 antibody staining was restricted to the basolateral membranes of the colonocytes. We speculate that distinct MCT isoforms may be involved in SCFA transport across the apical or basolateral membranes in polarized colonic epithelial cells.

3 April 2018 in Tissue Barriers
Verified
Journal Article
Open access
AAArivarasu N. Anbazhagan
Arivarasu N. Anbazhagan
SPShubha Priyamvada
Shubha Priyamvada
WAWaddah Alrefai
Waddah Alrefai
PDPradeep K Dudeja
Pradeep K Dudeja
Inflammatory bowel diseases broadly categorized into Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory disorders of the gastrointestinal tract with increasing prevalence worldwide. The etiology of the disease is complex and involves a combination of genetic, environmental, immunological and gut microbial factors. Recurring and bloody diarrhea is the most prevalent and debilitating symptom in IBD. The pathogenesis of IBD-associated diarrhea is multifactorial and is essentially an outcome of mucosal damage caused by persistent inflammation resulting in dysregulated intestinal ion transport, impaired epithelial barrier function and increased accessibility of the pathogens to the intestinal mucosa. Altered expression and/or function of epithelial ion transporters and channels is the principle cause of electrolyte retention and water accumulation in the intestinal lumen leading to diarrhea in IBD. Aberrant barrier function further contributes to diarrhea via leak-flux mechanism. Mucosal penetration of enteric pathogens promotes dysbiosis and exacerbates the underlying immune system further perpetuating IBD associated-tissue damage and diarrhea. Here, we review the mechanisms of impaired ion transport and loss of epithelial barrier function contributing to diarrhea associated with IBD.

13 November 2020 in Gastroenterology
Verified
Journal Article
Closed access
AKAnoop Kumar
Anoop Kumar
SPShubha Priyamvada
Shubha Priyamvada
YGYong Ge
Yong Ge
DJDulari Jayawardena
Dulari Jayawardena
MSMegha Singhal
Megha Singhal
PDPradeep K Dudeja
Pradeep K Dudeja

1 August 2004 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
PDF file
GHGail Hecht
Gail Hecht
KHKim Hodges
Kim Hodges
RGRavinder K. Gill
Ravinder K. Gill
FKFely Kear
Fely Kear
STSangeeta Tyagi
Sangeeta Tyagi
PDPradeep K Dudeja
Pradeep K Dudeja
Enteropathogenic Escherichia coli (EPEC) is an important human intestinal foodborne pathogen associated with diarrhea, especially in infants and young children. Although EPEC produces characteristic attaching and effacing lesions and loss of microvilli, the pathophysiology of EPEC-associated diarrhea, particularly during early infection, remains elusive. The present studies were designed to examine the direct effects of EPEC infection on intestinal absorption via Na+/H+exchanger (NHE) isoforms. Caco-2 cells were infected with EPEC strain E2348/69 or nonpathogenic E. coli HB101 for a period of 60 to 120 min. Total NHE activity was significantly increased at 60 min, reaching approximately threefold increase after 90 min of EPEC infection. Similar findings were seen in HT-29 cells and T84 cells indicating that the response was not cell-line specific. Most surprising was the differential regulation of NHE2 and NHE3 by EPEC. Marked activation of NHE2 (300%) occurred, whereas significant inhibition (∼50%) of NHE3 activity was induced. The activity of basolateral isoform NHE1 was also significantly increased in response to EPEC infection. Mutations that disrupted the type III secretion system (TTSS) ablated the effect of EPEC on the activity of both NHE2 and NHE3. These results suggest that EPEC, through a TTSS-dependent mechanism, exerts differential effects on NHE isoform activity in intestinal epithelial cells. Additionally, NHEs do not appear to play any role in EPEC-mediated inflammation, because the NHE inhibitors amiloride and 5-( N-ethyl- N-isopropyl)amiloride did not prevent EPEC-mediated IκBα degradation.

1 December 2015 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
SPShubha Priyamvada
Shubha Priyamvada
RGRochelle Gomes
Rochelle Gomes
RGRavinder K. Gill
Ravinder K. Gill
SSSeema Saksena
Seema Saksena
WAWaddah A. Alrefai
Waddah A. Alrefai
PDPradeep K Dudeja
Pradeep K Dudeja
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are chronic relapsing inflammatory disorders of the gastrointes

4 September 2007 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
ABAlip Borthakur
Alip Borthakur
SSSeema Saksena
Seema Saksena
RGRavinder Gill
Ravinder Gill
WAWaddah A. Alrefai
Waddah A. Alrefai
KRKrishnamurthy Ramaswamy
Krishnamurthy Ramaswamy
PDPradeep K Dudeja
Pradeep K Dudeja